Loading...

MannKind Corporation

MNKD•NASDAQ
Healthcare
Biotechnology
$3.56
$0.70(24.48%)
U.S. Market opens in 13h 31m

MannKind Corporation (MNKD) Stock Overview

Explore MannKind Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio189.49
EPS (TTM)$0.02
ROE-0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$2.58
3 Months$2.93
1 Year Target$5.51

MNKD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MannKind Corporation (MNKD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.14, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $5.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 189.49 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
24.48%
5-Day Change
25.80%
1-Month Change
39.06%
3-Month Change
-38.41%
6-Month Change
-37.54%
Year-to-Date (YTD) Change
-37.21%
1-Year Change
-25.52%
3-Year Change
-8.25%
5-Year Change
-12.75%
All-Time (Max) Change
-94.94%

Contact Information

https://www.mannkindcorp.com
818 661 5000
30930 Russell Ranch Road, Danbury, CA, 91362

Company Facts

403 Employees
IPO DateJul 28, 2004
CountryUS
Actively Trading

Frequently Asked Questions